Bioresorbable drug-eluting films can be used in many biomedical applications. Examples for such applications include biodegradable medical support devices which combine mechanical support with drug release and antibiotic-eluting film coatings for prevention of bacterial infections associated with orthopedic implants or during gingival healing. In the current study, bioresorbable drug-loaded polymer films are prepared by solution processing. Two film structures are studied: A polymer film with large drug crystals located on its surface (A-type) and a polymer film with small drug particles and crystals distributed within the bulk (B-type). The basic mode of drug dispersion/location in the film (A or B-type) is found to be determined mainly by the process of film formation and depends mainly on the solvent evaporation rate, whereas the drug's hydrophilicity has a minor effect on this structuring process. Most release profiles from A-type films exhibit a burst effect of ~30% and a second release stage that occurs at an approximately constant rate and is determined mainly by the polymer weight loss rate. An extremely high burst release is exhibited only by a very hydrophilic drug. The matrix (monolithic) nature of the B-type film enables release profiles that are determined mainly by the host polymer's degradation profile, with a very low burst effect in most of the studied systems. In addition to the drug location/ dispersion in the film, the host polymer and drug type also strongly affect the drug's release profile from the film. It has been demonstrated that appropriate selection of the process parameters and film components (polymer and drug) can yield film structures with desirable drug release behaviors. This can lead to the engineering of new bioresorbable drug-eluting film-based implants for various applications.
Park, Y.J., Lee, Y.M., Park, S.N., Lee, J.Y., Ku, Y., Chung, C.P. and Lee, S.J. (2000). Enhanced Guided Bone Regeneration by Controlled Tetracycline Release from Poly(L-lactide) Barrier Membranes, Journal of Biomedical Materials Research, 51(3): 391-397.
2.
Lee, K.B., Kang, S.B., Kwon, I.C., Kim, Y.H., Choi, K. and Jeong, S.Y. (1997). Controlled Release and in vitro Antimicrobial Activity of Gentamicin from Poly-α-hydroxy Acid Films, In: Proceedings of the 24th International Symposium on Controlled Release of Bioactive Materials, pp. 571-572.
3.
Mauduit, J., Bulkh, N. and Vert, M. (1993). Gentamicin/Poly(lactic acid) Blends Aimed at Sustained Release Local Antibiotic Therapy Administrated Per-operatively. III The Case of Gentamicin Sulfate in Films Prepared from High and Low Molecular Weight poly(DL-lactic Acids), Journal of Controlled Release, 25(1-2): 43-49.
4.
Zilberman, M. , Schwade, N., Meidell, R. and Eberhart, R. (2001). Structured Drug Loaded Bioresorbable Films for Support Structures, Journal of Biomaterials Science, Polymer Ed., 12: 875-892.
5.
Zilberman, M. , Eberhart, R.C. and Schwade, N.D. (2002). In-vitro Study of Drug Loaded Bioresorbable Films and Support Structures, Journal of Biomaterials Science Polymer, 13: 1221-1240.
6.
Wang, X., Venkatraman, S.S., Boey, F.Y.C., Loo, J.S.C. and Tan, L.P. (2006). Controlled Release of Sirolimus from a Multilayered PLGA Stent Matrix, Biomaterials, 27: 5588-5595.
7.
Dorta, M.J., Santovena, A., Liabres, M. and Farina, J.B. (2002). Potential Applications of PLGA Film-implants in Modulating In-vitro Drugs Release, International Journal of Pharmaceutics, 248: 149-156.
8.
Livnat, M., Beyar, R. and Seliktar, D. (2005). Endoluminal Hydrogel Films Made of Alginate and Polyethylrnr Glycol: Physical Characteristics and Drug-eluting Properties , Journal of Biomedical Materials Research Part A, 75A: 710-722.
9.
Westedt, U., Wittmar, M., Hellwig, M., Hanefeld, P., Greiner, A., Schaper, A.K. and Kissel, T. (2006). Paclitaxel Releasing Films Consisting of Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide) and their Potential as Biodegradable Stent Coatings, Journal of Controlled Release, 111: 235-246.
10.
Cetin, E.O., Buduneli, N., Athhan, E. and Kurilmaz, L. (2005). In-vitro Studies of a Degradable Device for Controlled-release of Meloxicam, J. Clin. Periodontol., 32: 773-777.
11.
Quaglia, F., Vignole, M.C., De Rosa, G., La Rotonda, M.I., Maglio, G. and Palumbo, R. (2002). New Segmented Copolymers Containing Poly(ε-caprolactone) and Etheramide Segments for the Controlled Release of Bioactive Compounds , Journal of Controlled Release, 83: 263-271.
12.
Tarvainen, T. , Karjalainen, T., Malin, M., Perakorpi, K., Tuominen, J., Seppala, J. and Jarvinen, K. (2002). Drug Release Profiles from and Degradation of a Novel Biodegradable Polymer, 2,2-bis(2-oxazoline) Linked Poly(ε-caprolactone), European Journal of Pharmaceutical Sciences, 16: 323-331.
13.
Zilberman, M. (2005). Dexamethasone Loaded Bioresorbable Films used in Medical Support Devices: Structure, Degradation, Crystallinity, and Drug Release, Acta Biomaterialia, 1(6): 615-625.
14.
Kodama, M., Numaga, J., Yoshida, A., Kaburaki, T., Oshika, T., Fujino, Y., Wu, G.S., Rao, N.A. and Kawashima, H. (2003). Effects of New Dexamethasone-delivery System (Surodex) on Experimental Intraocular Inflammation Models, Graefes Archive for Clinical and Experimental Ophthalmology, 241(11): 927-933.
15.
Kagaya, F., Usui, T., Kamiya, K., Ishii, Y., Tanaka, S., Amano, S. and Oshika, T. (2002). Intraocular Dexamethasone Delivery System for Corneal Transplantation in an Animal Model, Cornea, 21(2): 200-202.
16.
Leopold, C.S. and Eikeler, D. (2000). Basic Coating Polymers for the Colon-specific Drug Delivery in Inflammatory Bowel Disease, Drug Development and Industrial Pharmacy, 26912: 1239-1246.
17.
Nakase, H., Okazaki, K., Tabata, Y. and Chiba, T. (2003). Biodegradable Microspheres Targeting Mucosal Immune-regulating Cells: New Approach for Treatment of Inflammatory Bowel Disease, Journal of Gastroenterology, 38: 59-62.
18.
Dev, V. , Eigler, N., Fishbein, M.C., Tian, Y., Hickey, A., Rechavia, E., Forrester, J.S. and Litvack, F. (1997). Sustained Local Drug Delivery to the Arterial Wall via Bioresorbable Microspheres, Catheterization and Cardiovascular Diagnosis, 41(3): 324-332.
19.
Guzman, L.A. , Labhasetwar, V., Song, C., Jang, Y., Linkoff, A.M., Levy, R. and Topol, E.J. (1996). Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles. A Novel Approach for Prolonged Drug Delivery after Balloon Angioplasty, Circulation, 94(6): 1441-1448.
20.
Lincoff, A.M. , Furst, J.G., Ellis, S.G., Tuch, R.J. and Topol, E.J. (1997). Sustained Local Delivery of Dexamethasone by Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model, Journal of the American College of Cardiology, 29(4): 806-816.
21.
Kanellakopoulou, K. and Giamarellos-Bourboulis , E.J. (2000). Carrier Systems for the Local Delivery of Antibiotics in Bone Infections, Drugs, 59(6): 1223-1232.
22.
Yang, J.M., You, J.W., Chen, H.L. and Shih, C.H. (1996). Calorimetric Characterization of the Formation of Acrylic Type Bone Cements, J. Biomed. Mater. Res., 33(2): 83-88.
23.
Price, J.S., Tencer, A.F., Arm, D.M. and Bohach, G.A. (1996). Controlled Release of Antibiotics from Coated Orthopedic Implants, Journal of Biomedical Materials Research , 30: 281-286.
24.
Gollwitzer, H. , Ibrahim, K., Meyer, H., Mittelmeier, W., Busch, R. and Stemberger, A. (2003). Antibacterial Poly(D,L-lactic acid) Coating of Medical Implants using a Biodegradable Drug Delivery Technology , J. Antimicrobial Chemotherapy, 51: 585-591.
25.
Lucke, M., Schmidmaier, G., Sadoni, S., Wildemann, B., Schiller, R., Haas, N.P. and Raschke, M. (2003). Gentamicin Coating of Metallic Implants Reduces Implant-related Osteomyelitis in Rats, Bone, 32: 521-531.
26.
Schmidt, C., Wenz, R., Nies, B. and Moll, F. (1995). Antibiotic in vivo/in vitro Release, Histocompatibility and Biodegradation of Gentamicin Implants Based on Lactic Acid Polymers and Copolymers, J. Controlled Release, 37: 83-94.
27.
Gursel, I., Korkusuz, F., Turesin, F., Alaeddinoglu, N.G. and Hasirci, V. (2001). In vivo Application of Biodegradable Controlled Antibiotic Release Systems for the Treatment of Implant-related Osteomyelitis , Biomaterials, 22: 73-80.
28.
Zhang, X., Wyss, U.P., Pichora, D. and Goosen, M.F.A. (1994). Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release Properties, J. Pharm. Pharmacol., 46(9): 718-724.
29.
Pähkla, E.R. , Koppel, T., Saag, M. and Pähkla, R. (2005). Metronidazole Concentrations in Plasma, Saliva and Periodontal Pockets in Patients with Periodontitis, Journal of Clinical Periodontology, 32: 163-166.
30.
Lamp, K.C., Freeman, C.D., Klutman, N.E. and Lacy, M.K. (1999). Pharmacokinetics and Pharmacodynamics of Nitronidazole Antimicrobials, Clinical Pharmacokinetics, 36(5): 353-373.
31.
Perioli, L. , Ambrogi, V., Rubini, D., Giovagnoli, S., Ricci, M., Blasi, P. and Rossi, C. (2004). Novel Mucoadhesive Buccal Formulation Containing Metronidazole for the Treatment of Periodontal Disease , Journal of Controlled Release, 95(3): 521-533.
32.
Golomb, G., Friedman, M., Soskolne, A., Stabholz, A. and Sela, M.N. (1984). Sustained Release Device Containing Metronidazole for Periodontal Use, Journal of Dental Research, 63(9): 1149-1153.
33.
Austin, M.N. , Meyn, L.A. and Hillier, S.L. (2006). Susceptibility of Vaginal Bacteria to Metronidazole and Tinidazole, Anaerobe, 12(5-6): 227-230.
34.
Wu, Y. and Fassihi, R. (2005). Stability of Metronidazole, Tetracycline HCl and Famotidine Alone and in Combination, International Journal of Pharmaceutics, 290(1-2): 1-13.
35.
Chourasia, M.K. and Jain, S.K. (2004). Design and Development of Multiparticulate System for Targeted Drug Delivery to Colon, Drug Deliver, 11(3): 201-217.
36.
Varshosaz, J., Tavakoli, N. and Saidian, S. (2002). Development and Physical Characterization of a Periodontal Bioadhesive Gel of Metronidazole, Drug Delivery, 9(2): 127-133.
37.
Perioli, L. , Ambrogi, V., Rubini, D., Giovagnoli, S., Ricci, M., Blasi, P. and Rossi, C. (2004). Novel Mucoadhesive Buccal Formulation Containing Metronidazole for the Treatment of Periodontal Disease , Journal of Controlled Release, 95(3): 521-533.
38.
Murata, Y., Kofuji, K. and Kawashima, S. (2003). Preparation of Floating Alginate Gel Beads for Drug Delivery to the Gastric Mucosa, Journal of Biomaterials Science, Polymer Edition 2003, 14(6): 581-588.
39.
Lewis, D.D. (1990). Controlled Release of Bioactive Agents from Lactide/ Glycolide Polymers, In: Chasin, M. and Langer, R.S. (eds), Biodegradable Polymers as Drug Delivery Systems, pp. 1-41, Marcel Dekker, New York.
40.
Sampath, S.S. and Robinson, D.H. (1990). Comparison of New and Existing Spectrophotometric Methods of Analysis of Tobramycin and Other Aminoglycosides , J. Pharm. Sci., 79: 428-431.
